<!DOCTYPE html>
<html lang="en">

<head>

<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="format-detection" content="telephone=no" />

<link rel="icon" href="drive-icon.png" />
<link rel="apple-touch-icon" href="img/drive-apple-icon.png" />

<meta name="robots" content="index,follow" />

<meta name="keywords" content="" />
<meta name="description" content="DRIVe is transforming health security innovation to protect Americans from 21st century health security threats" />
<meta name="author" content="Barda DRIVe" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="@BARDA" />
<meta name="twitter:title" content="ReDIRECT" />
<meta name="twitter:description" content="A joint effort with Chemical Medical Countermeasures Branch to establish partnerships with innovators to repurpose commonly available therapeutics for rapid use in the event of exposure to chemical agents." />
<meta name="twitter:image" content="https://drive.hhs.gov/img/twittercard_redirect.png" />
<meta name="twitter:image:alt" content="Banner for DRIVe ReDIRECT" />

<title>DRIVe</title>
<!--	
<meta http-equiv="Refresh" content="0; url=https://www.google.com">
-->
	
<!-- Custom Fonts -->
<link href="https://fonts.googleapis.com/css?family=Raleway" rel="stylesheet">
<link href="font-awesome/css/font-awesome.min.css" rel="stylesheet" type="text/css">
	
<!-- Version 5.0 for checkmark -->
	<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.5.0/css/all.css" integrity="sha384-B4dIYHKNBt8Bc12p+WXckhzcICo0wtJAoU8YZTY5qE0Id1GSseTk6S+L3BlXeVIU"
	 crossorigin="anonymous">

<!-- Bootstrap Core CSS -->
<link href="css/bootstrap.min.css" rel="stylesheet">

<!-- Custom CSS -->
<link href="css/theme.css" rel="stylesheet">

<link href="css/flipclock.css" rel="stylesheet">

<!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
<!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
<!--[if lt IE 9]>
		<script src="/drivepubhtml/js/ie/html5shiv.js"></script>
		<script src="/drivepubhtml/js/ie/respond.min.js"></script>
	<![endif]-->
<!-- D3.js 03/02/20 -->
<script src="map/js/d3.v4.min.js"></script>
<script src="map/js/d3-scale-chromatic.v1.min.js"></script>

<!-- jQuery -->
<script src="js/jquery-min.js"></script>

<!-- Needed for tooltips -->
<script src="js/popper.min.js"></script>

<!-- Bootstrap Core JavaScript -->
<script src="js/bootstrap.min.js"></script>

<!-- ParaParse -->
<script src="js/PapaParse-4.6.0/papaparse.min.js"></script>
	
<!-- Make portfolio -->
<script src="js/makePortfolio.js"></script>

<!-- FlipClock Counter -->
<script src="js/flipclock.min.js"></script>
	
<!-- Flipclock -->
	
  <style>
.flipcounter {
	
transform-origin: 0 0;
transform: scale(.30);
-ms-transform: scale(.30);
-webkit-transform-origin: 0 0;
-webkit-transform: scale(.80);
-o-transform-origin: 0 0;
-o-transform: scale(.30);
-moz-transform-origin: 0 0;
-moz-transform: scale(.70);
margin-left: 60px;

}

	</style>
    <script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-36251023-1']);
  _gaq.push(['_setDomainName', 'jqueryscript.net']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
	
	<link href="js/FlipClockCountdown/src/jquery.counter-analog.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="js/FlipClockCountdown/src/jquery.counter-analog2.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="js/FlipClockCountdown/src/jquery.counter-analog3.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="css/solvingsepsis.css" rel="stylesheet" type="text/css">
    <script src="js/FlipClockCountdown/src/jquery.counter.js" type="text/javascript"></script>
	
<!-- Footer Include -->
	<script> 
    $(function(){
      $("#includefooter").load("footer.html"); 
    });
    </script> 
	
	<!-- Header Include -->
	<script> 
    $(function(){
      $("#includeheader").load("header.html"); 
    });
    </script> 
	
	<!-- Generate portfolio -->
	<script>
		$(function () {
		var csvfile = "map/data/ProductList_20180913.csv";
		// parseCSVToCallback(csvfile, makeGallery, "Sepsis");    // 03/02/20
		parseCSVToCallbackUpdate();                               // 03/02/20
		})
	</script>
	
		<script>	
		function makeCounter(startingValue, timeInterval, idOfHTML) {
			var clock = $(idOfHTML).FlipClock(startingValue, {
			clockFace: 'Counter'
			});
			var count = 0;
			setTimeout(function() {
				setInterval(function() {
					clock.increment();
				}, 
				timeInterval);
			});
		};
			
		// 86400 seconds per day
		const msPerDay = 86400 * 1000; // 60 * 60 * 24 = 86400
		
		const casesPerDay = 4658; // = 1.7M / 365 days
		// const deathsPerDay = 740;
		var msPerCase = msPerDay / casesPerDay;
		// var msPerDeath = msPerDay / deathsPerDay;
		
		// Find out how many milliseconds have elapsed thus far this year (automatically updating for each year)
		var msTotalThisYear = new Date() - new Date("1/1/" + (new Date()).getFullYear());
			
		// Once the page renders, start the counters
		$(function() {
			// Cases
			makeCounter(Math.round(msTotalThisYear / msPerCase), msPerCase, "#counter-diagnoses");
			// makeCounter(Math.round(msTotalThisYear / msPerDeath), msPerDeath, "#counter-deaths");
		});
	</script>
	
	
	

<script>
	$(document).ready(function(){
		$("[data-toggle='tooltip']").tooltip();
	});
</script>

</head>

<body id="page-top" class="index">
    <!-- Google Tag Manager -->
    <script>
        (function (i, s, o, g, r, a, m) {
            i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                (i[r].q = i[r].q || []).push(arguments)
            }, i[r].l = 1 * new Date(); a = s.createElement(o),
            m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g; m.parentNode.insertBefore(a, m)
        })(window, document, 'script', 'https://www.google-analytics.com/analytics.js', 'ga');

        ga('create', 'UA-122497508-1', 'auto');
        ga('send', 'pageview');

    </script>
    <!-- End Google Tag Manager -->

    <!-- Navigation -->
	<div id="includeheader"></div>
    <!-- End Navigation -->
	
		<!-- Header -->
	<header style="border-bottom: 1px solid #efefef; padding-bottom: 20px;" id="banner">
		<div class="jumbotron services"
			style="background-color: #FFFFFF;">
			<div class="container">
				<div class="row">
					<div class="col-lg-12 banner-text-container">
						<div class="banner-text">
							<div class=" green">
								<div class="home-banner-heading">
								  <h3 class="title" style="letter-spacing: 8px; color: #282828; font-size: 40px; text-transform: uppercase">NGS-based Agnostic Diagnostic</h3>
								  <br />
</div>
							</div>
						</div>
					</div>
				</div>
			</div>
		</div>
	</header>
		<br><br>
	<section>
			<div class="container">
				<div class="row">
					
				<div  class="col-lg-8 text-left"><br>
					<div>
<h2 style="padding-left: 0px">About NGS-based Agnostic Diagnostic</h2>					
<p>An agnostic test to detect any respiratory RNA virus, including new and emerging viruses, that can be implemented rapidly and without the need for additional regulatory approvals in future pandemic situations. 
</p>
</div>
					
					</div>
					<div style="margin: 0px;" class="col-lg-4 text-center">
					  	<img alt="syringe"  style="max-height: 230px; margin-top: 50px" class="img-fluid" src="img/ngs_logo_circle.png">
					</div>

			</div>
		</div>
		</section>

	<br><br>

    
		<div style="-webkit-box-shadow: -1px 11px 15px -5px rgba(0,0,0,0.35); 
box-shadow: -1px 11px 15px -5px rgba(0,0,0,0.35);" class="container">
  <div class="row">
   <div  class="col-12">
      <ul class="nav nav-tabs ">
        <li><a role="tab" class="active" href="#tab1" data-toggle="tab">Overview</a></li>
     <!--  <li><a role="tab" href="#tab2" data-toggle="tab">Vision</a></li>--> 
    	 <li><a role="tab" href="#tab3" data-toggle="tab">FAQ</a></li>
		 <li><a role="tab" href="#tab4" data-toggle="tab">Webinars</a></li>
		<!--  <li><a role="tab" href="#tab5" data-toggle="tab">BtN is Personal</a></li>-->
      </ul>
      <div class="tab-content ">
          <div role="tabpanel" class="tab-pane active" id="tab1">
		  <div class="row">  
			  <div class="col-sm-12 text-center">
			    <h3>Overview</h3>
			    <hr />
		<br>
	</div>
  </div>
	<div class="row text-left"> 
		<div style="padding-bottom: 30px;" class="col-sm-10 mx-auto">

<p>Next-generation sequencing diagnostics have been established for oncology and some genetic disorders, and such technology  is also needed for infectious diseases due to  health security threats. In a viral outbreak or pandemic, having agnostic tests – which can detect any respiratory RNA virus and can be implemented rapidly without the need for additional regulatory approvals – is crucial. </p>
	<p>NGS technology can detect and analyze viral genomes from any existing or emerging viruses in an unbiased manner compared to targeted polymerase chain reaction (PCR) and antigen assays. PCR and antigen assays require a significant effort to develop, verify, validate, as well as earn regulatory approval. In pandemic situations, next-generation sequencing assays could provide the capability for agnostic detection ability, especially with emerging respiratory pathogens and can be used on day one with appropriate regulatory approval. These tests also provide information crucial to timely and actionable patient care. </p>
	<p>Despite the promise of next-generation sequencing, the commercialization of such platforms has not yet occurred, and no U.S. Food and Drug Administration (FDA)-cleared agnostic diagnostic currently exists for use in pandemic situations.</p>
	<p>Our focus is to further verify and validate the existing NGS-based assays for detection of respiratory RNA viruses, and support them through FDA approval. We expect that this approach will help to prepare the U.S. and potentially the world for future pandemics involving respiratory RNA pathogens. Expanding on this technology eventually could open up other opportunities for agnostic infectious disease diagnostics. 
	
	  </p>


		</div>
			
        </div>
		  </div>
    <!--   <div role="tabpanel" class="tab-pane" id="tab2">
		<div class="container">
	 <div class="row">  
			  <div class="col-sm-12 text-center">
			    <h3>Vision</h3>
			    <hr />
				  
				  
<br>
				  <div class="text-left">
<p>An agnostic test to detect any respiratory RNA virus, including new and emerging viruses, that can be implemented rapidly and without the need for additional regulatory approvals in future pandemic situations. </p>

</div>
	</div>
  </div>     
       </div>
      </div> -->
        <div role="tabpanel" class="tab-pane" id="tab3">
      <div class="row">
		  <br />
		  <div class="col-sm-12 text-center">
		    <h3>FAQ</h3>
		    <hr /></div>
  	<div class="col-lg-12">
			<div class="container-fluid bg-gray" id="accordion-style-2">
	<div class="container">
		<section>
			<div class="row">
				<div class="col-12">
				 
				<div class="col-11 mx-auto">
					<div class="accordion" id="accordionExample2">
								<div class="card">
							<div class="card-header" id="headingThirteenCollapse2">
								<h5 class="mb-0">
							<button class="btn btn-link btn-block text-left" type="button" data-toggle="collapse" data-target="#collapseThirteenCollapse2" aria-expanded="true" aria-controls="collapseThirteenCollapse2"><em class="fa fa-plus main"></em>Is the NGS-based agnosic diagnostic open to academics or do only companies qualify?</button>
						  </h5>
							</div>

							<div id="collapseThirteenCollapse2" class="collapse show fade" aria-labelledby="headingThirteenCollapse2" data-parent="#accordionExample2">
								<div class="card-body">
									<p>It is open to both academia and industries as long as the respondents meet all the requirements described in EZ-BAA.</p>
								</div>
							</div>
						</div>
							<div class="card">
							<div class="card-header" id="headingZeroCollapse2">
								<h5 class="mb-0">
							<button class="btn btn-link btn-block collapsed text-left" type="button" data-toggle="collapse" data-target="#collapseZeroCollapse2" aria-expanded="false" aria-controls="collapseZeroCollapse2"><em class="fa fa-plus main"></em>Can large companies apply to NGS-based agnostic diagnostic program?</button>
						  </h5>
							</div>

							<div id="collapseZeroCollapse2" class="collapse fade" aria-labelledby="headingZeroCollapse2" data-parent="#accordionExample2">
								<div class="card-body">
									<p>Any entity can submit proposal via the EZ-BAA portal as long as they are registered with <a href="https://sam.gov/content/home">www.SAM.gov</a>.</p>
								</div>
							</div>
						</div>
						<div class="card">
							<div class="card-header" id="headingOneCollapse2">
								<h5 class="mb-0">
							<button class="btn btn-link collapsed btn-block text-left" type="button" data-toggle="collapse" data-target="#collapseOneCollapse2" aria-expanded="false" aria-controls="collapseOneCollapse2"><em class="fa fa-plus main"></em>Can companies/universities outside of the United States apply for this funding?</button>
						  </h5>
							</div>

							<div id="collapseOneCollapse2" class="collapse fade" aria-labelledby="headingOneCollapse2" data-parent="#accordionExample2">
								<div class="card-body">
									<p>Yes. Applicants from outside of the United States are eligible to apply for funding. Please note though that U.S.-based manufacturing of the proposed solution device/diagnostic will be prioritized.</p>
								</div>
							</div>
						</div>
						<div class="card">
							<div class="card-header" id="headingTwoCollapse2">
								<h5 class="mb-0">
							<button class="btn btn-link collapsed btn-block text-left" type="button" data-toggle="collapse" data-target="#collapseTwoCollapse2" aria-expanded="false" aria-controls="collapseTwoCollapse2"><em class="fa fa-plus main"></em>Do academic institutions also need to provide a 30% cost share?</button>
						  </h5>
							</div>
							<div id="collapseTwoCollapse2" class="collapse fade" aria-labelledby="headingTwoCollapse2" data-parent="#accordionExample2">
								<div class="card-body">
									<p>Yes. Abstract submissions should include a cost-share that is within our target range of 30-50% minimum unless you satisfy the regulatory exception described (included below for reference). Currently, none of the awardees under the DRIVe EZ-BAA have been awarded a contract that does not include a cost-share component below range, including all universities and non-profit organizations. Cost-share may be in-kind or cash contributions. It may also come from a third-party investor/sponsor; however, it is up to you to ensure you receive their contribution toward the proposed project. Many organizations offer to cover Overhead or Fringe Benefits. Some also offer pro-bono labor hours or sponsored equipment, materials, or subcontractor costs. A combination of all of the above could be acceptable. It would need to be indicated on a submission what is being cost-shared. To qualify for no cost-share under an EZ-BAA award, a respondent must show that there is "no probability that the respondent will receive present or future benefits from participation as described in Federal Acquisition Regulation (FAR) 16.303." Examples of present or future benefits include increased technical know-how, training for employees, acquisition of goods or services, development of a commercially viable product that can be sold in the commercial market, and use of background knowledge in future contracts.
</p>
								</div>
							</div>
						</div>
						<div class="card">
							<div class="card-header" id="headingThreeCollapse2">
								<h5 class="mb-0">
							<button class="btn btn-link collapsed btn-block text-left" type="button" data-toggle="collapse" data-target="#collapseThreeCollapse2" aria-expanded="false" aria-controls="collapseThreeCollapse2">
							  <i class="fa fa-plus main"></i>What are the data sharing requirements of the NGS-based Agnostic Diagnostic Program?
							</button>
						  </h5>
							</div>
							<div id="collapseThreeCollapse2" class="collapse fade" aria-labelledby="headingThreeCollapse2" data-parent="#accordionExample2">
								<div class="card-body"> <p>NGS-based agnostic diagnostic projects have data sharing requirements with the U.S. government consistent with government regulation (FAR 52.227-14 Rights in Data). The program requires that you share all data (including raw data) generated under the project for government’s use consistent with the regulation.</p></div>
							</div>
						</div>
						<div class="card">
							<div class="card-header" id="headingFourCollapse2">
								<h5 class="mb-0">
							<a href="#" class="btn btn-link collapsed btn-block text-left"  data-toggle="collapse" data-target="#collapseFourCollapse2" aria-expanded="false" aria-controls="collapseFourCollapse2">
							  <i class="fa fa-plus main"></i>The EZ-BAA application is so short. Can I include links to figures or references?
									</a>
						  </h5>
							
							</div>
							<div id="collapseFourCollapse2" class="collapse fade" aria-labelledby="headingFour" data-parent="#accordionExample2">
								<div class="card-body">
									<p>While you can include links to figures or references, it is not mandated that reviewers view that outside information. At this time, the abstract format does not accept any figures, only text.
</p>
								</div>
							</div>
						</div>
				
				
					
				
					<br><br>
					
				
						
					</div>
					</div>
				</div>	
			</div>
		</section>
	</div>
</div>			
			</div> 

  </div> 
		  </div>

		  <div role="tabpanel" class="tab-pane" id="tab4">
			<div class="container">
		 <div class="row">  
				  <div class="col-sm-12 text-center">
					<h3>Webinars</h3>
					<hr />
					  
					  
	<br>
					  <div class="text-center">
						<h5>Please check back for future webinars</h5><br><br>
					</div>
		</div>
	  </div>     
		   </div>
		  </div>

		  

			</div>
       </div>
		  

		  
		  
      </div>
    </div>

 
	<br /><br />
	<div class="container">
	<div style="text-align: center">For more information, please contact us at <a href="mailto:NGS@hhs.gov">NGS@hhs.gov</a></div><br>
		<div style="text-align: center">Submit your <a target="_blank" href="https://sam.gov/opp/4a438db52d9b422986d28c18b709b570/view">EZ BAA Abstract</a></div><br>
    </div>


	<!--   END: TAB CONTENT -->
	
	

<!-- Footer -->
 <div id="includefooter"></div>
<!-- Footer --------->
	

	<!-- Scroll to Top Button (Only visible on small and extra-small screen sizes) -->
	<div id="scroll-top-link"
		class="scroll-top page-scroll visible-xs visible-sm">
		<a class="btn btn-primary" href="#page-top"> <i
			class="fa fa-chevron-up"></i>
		</a>
	</div>
</body>

</html>

